Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford Medical School remains top for student satisfaction

General

For the eighth year running, the University of Oxford’s Medical School is ranked highest of all UK medical school in terms of student satisfaction.

Image courtesy of Shutterstock

The result comes from the National Student Survey, an annual online survey of all final year students in all degree courses in UK Higher Education Institutions. In the survey, 98% of Oxford medical students answered ‘agree’ or ‘definitely agree’ to the question “Overall, I am satisfied with the quality of the course.” Additionally, 87% of these students answered this question with ‘definitely agree’: by far the highest proportion in any UK medical school.

Professor David Paterson, Deputy Head & Vice Dean Medical Sciences Division (Education) commented: 'This is a very pleasing outcome and continues to demonstrate the outstanding commitment of our colleagues in providing a first class student experience in a research intensive environment.'

Dr Tim Lancaster, Director of Clinical Studies said, “This year, for the first time, the General Medical Council published pass rates for  postgraduate examinations in all medical specialties by medical school of origin. This analysis showed that Oxford graduates achieved higher levels of success than graduates of all other  UK medical schools. We are very pleased that Oxford has such positive outcomes for both these quality indicators, student satisfaction and graduate achievement.’

Links:

Similar stories

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.